| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |